跳至主要内容
临床试验/ChiCTR2100054748
ChiCTR2100054748招募中Unknown

The efficacy and safety of MateRegen gel to prevent intrauterine adhesion after surgical evacuation: A prospective randomized controlled trial

N/A`1 个研究点 分布在 1 个国家目标入组 172 人开始时间: 2022年1月1日最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
172
试验地点
1
主要终点
Presence of intrauterine adhesions

研究概览

简要总结

The objective of this prospective, randomized controlled study was to evaluate the effectiveness of this NCH gel in the prevention of IUA development as assessed by hysteroscopy after surgical evacuation, including both tradition surgical evacuation and USG-MVA, in the treatment of first trimester miscarriage after surgical evacuation.

研究设计

研究类型
Interventional
主要目的
随机平行对照
盲法
None

入排标准

年龄范围
18 至 50(—)
性别
Female

入选标准

  • 1.All women undergoing USG-MVA or traditional surgical evacuation with EVA or D&C for the treatment of early pregnancy loss with gestation < 12weeks;
  • 2.Women 18 years old or above;
  • 3.No previous history of IUA/ Ashermans syndrome;
  • 4.No previous history of therapeutic hysteroscopic surgeries;
  • 5.Agreeing to use adequate contraception throughout the follow-up period and to attend the follow-up examination according to study protocol.

排除标准

  • Previous therapeutic hysteroscopic procedures (e.g. endometrial ablation, removal of fibroids or polyps, surgical correction of congenital uterine anomalies or adhesiolysis);
  • Suspicion of molar pregnancy;
  • Genital tract malformation;
  • Suspicion of active infection or genital tract malignancy or genital tuberculosis;
  • Abnormal blood coagulation;
  • Inability to tolerate pelvic examination known;
  • Suspected intolerance or hypersensitivity to NCH gel or its derivatives like cosmetic products;
  • Patient refusal.

研究组 & 干预措施

1

surgical evacuation with NCH gel

2

surgical evacuation alone

结局指标

主要结局

Presence of intrauterine adhesions

时间窗: 8-12 weeks' time from their USG-MVA or surgical evacuation procedure

次要结局

未报告次要终点

研究者

发起方
N/A`

研究点 (1)

Loading locations...

相似试验